Exciting new article: Clinician's Artificial Intelligence Checklist and Evaluation Questionnaire: Tools for Oncologists to Assess Artificial Intelligence and Machine Learning Models | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @ascocancer.bsky.social

JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social

America in 2025 or Hollow Knight: Silksong? www.mcsweeneys.net/articles/ame...

Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Evaluating the Minimal Common Oncology Data Elements Suitability in Enhancing Clinical Observational Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI #mCODE

Review and Commentary on Digital Pathology and Artificial Intelligence in Pathology | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Safe and Responsible Use of Artificial Intelligence in Health Care: Current Regulatory Landscape and Considerations for Regulatory Policy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Machine Learning Model Integrating Computed Tomography Image–Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Extraction of Social Determinants of Health From Electronic Health Records Using Natural Language Processing | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... #JCOCCI

Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Disparities in Patient Portal Messaging Among Oncology Patients Enrolled in the Patient Portal | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI

Reliability of Large Language Model Knowledge Across Brand and Generic Cancer Drug Names | JCO Clinical Cancer Informatics ascopubs.org/doi/abs/10.1... #JCOCCI @daniellebitterman.bsky.social

I heard this morning that my informatics colleague Dr. Atul Butte passed after a battle with cancer. He was a giant in the field & inspired many of us over his distinguished career. He was a passionate champion of the power of big data & his impact on our field is immeasurable. RIP Atul & thanks.

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...

Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...

So…about AI’s energy use… “…to create a five-second video, a newer AI model uses ‘about 3.4 million joules, more than 700 times the energy required to generate a high-quality image’. That's the equivalent of running a microwave for over an hour.”

Telehealth and Emergency Department Use Among Commercially Insured, Medicaid, and Medicare Patients Receiving Systemic Cancer Therapy in Washington State After COVID-19 | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10.... @emiliemgunn.bsky.social

Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in @statnews.com

Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....

Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....

Our new article evaluating commercial LLMs head-to-head on summarizing multiple myeloma treatments is now published, check it out! www.frontiersin.org/journals/dig... @smrubinstein.bsky.social @ecquis.bsky.social

We issued a new guideline update on systemic therapy in patients with metastatic castration-resistant prostate cancer. #mCRPC Read more: brnw.ch/21wSrFa

Honored to be a featured voice for #ASCO25 Will be sharing highlights from a patient/research advocacy perspective & likely focus in digital health interventions, supportive care advances, and diagnostics that lead to treatment optimization & risk mitigation TY @ascocancer.bsky.social for the oppty

Our new weekly content update is now available: hemonc.org/wiki/Weekly_.... @peteryang.hemonc.org @ecquis.bsky.social

Telepathy will make my job so much easier, can you also factor it into the score? Maybe ultraviolet ring colors?

A trio of LLMs were concordant w/ tumor board recommendations and/or NCCN/ESMO guidelines 75-87% of the time for 112 early BC cases. But gaps included NOT recommending genomic tests in N1 HR+ a la RxPONDER. I find it odd that was missed. IMO: promising, not yet great ascopubs.org/doi/full/10....

We are committed to supporting #CancerCare providers and patients who may be affected by public health issues. A listing of measles and vaccination resources can be found on our website and will continue to be updated: asco.org/news-initiat...

Attention to reproductive care is essential before cancer therapy begins.” Our latest ‘Science in Seconds’ features Dr. Alison Loren and Dr. Hui-chun Irene Su discussing our updated fertility preservation guideline. Learn more about this guideline: brnw.ch/21wRrAm

I have the pleasure to serve as the Vice Chair for Translational Bioinformatics and Precision Medicine track at the AMIA Informatics Summit #IS25. Looking forward to attending these fantastic sessions!

There are concerns that Bluesky's impact has faded since the initial hype. This is false. That impression results from reading headlines about social media instead of the hard data. The five HIGHEST points of Bluesky posts mentioning research all occur in the last 2 weeks.

Check out our new article, "Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: An international cohort study in cancer patients with SARS-CoV-2 infection". Open access link: authors.elsevier.com/sd/article/S... #CCC19

Hot.Off.The.Press. Published today in @ascocancer.bsky.social JCO Clinical Cancer Informatics: Early Circulating Tumor DNA Kinetics as a Dynamic Biomarker of Cancer Treatment Response. Provocative study by grad student Aaron Li with Drs. Kevin Leder and Jasmine Foo. ascopubs.org/doi/pdf/10.1...

Starting to fill up around here - c’mon down! @standupforscience.bsky.social

TODAY IS THE DAY! 🧪☀️⬇️ Join us at the Lincoln Memorial or your local site to Stand Up for Science!

Reminder: Amazon Blackout—starting tomorrow. Amazon ❌, Whole Foods ❌ off the to-do list!

I am not going to call this a Bluetorial, because I do not want to sully that term (which, at least I, find joyful). Let’s call it a Orwellial.

As we can expect PubMed dysfunction more and more or to be swamped with fake journals I suggest you get acquainted to this nice alternative: europepmc.org

This is going to be a big problem. Not typically on pubmed (a free online database of medical literature) on Saturday nights but heard it was down and had to check for myself.

Exciting news! The JCO Journals LinkedIn page is now live! Your dedicated hub for the latest breakthroughs, expert insights, and practical guidance from all six ASCO journals. Follow now for real-time updates and invaluable resources: brnw.ch/21wQXN7

"These results demonstrate the feasibility of implementing natural language processing tools in the routine of a cancer center to extract and code valuable information from pathology reports." ascopubs.org/doi/10.1200/... #JCOCCI #JCOJournals #OpenAccess

🚨 10 Days Until Stand Up for Science, and some HUGE NEWS! - Take Action With Us! 🚨 We’re excited to announce 32 official Stand Up for Science events happening across the country on March 7th! 🧵⬇️

Science in the 'Burgh I am planning to be there and looking forward to seeing you there too (if you are local and available)

"… it is the words and actions of all members of the scientific community … that form the collective voice of science …," writes @holdenthorp.bsky.social in a new #ScienceEditorial. scim.ag/4hR6ux0

Some good-ish news from NIH “Federal Register notices for study sections run by CSR (but not those by ICs) will start being permitted again” As far as I know, the timing for this is not clear, but I will be checking the Federal Register.

Our latest weekly content update available: hemonc.org/wiki/Weekly_.... @kotharishalin.bsky.social discusses SYMPATICO (ibrutinib-venetoclax for #MCL) and the ARIEL4 update is finally published - the results of which led to partial FDA withdrawal of rucaparib back in 2022. @peteryang.hemonc.org

Stand Up For #Science Rally in #RhodeIsland!! March 7th 12-4pm #RI Capitol! standupforscience2025.org/providence-ri/

Informative paper that addresses a question I have always had: What proportion of people with #cancer (PWC) in the US cross state lines for care?? 1/4 #oncsky #medsky pubmed.ncbi.nlm.nih.gov/39982726/